Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease.
about
Rivastigmine for Alzheimer's diseaseRivastigmine for Alzheimer's diseaseRivastigmine for Alzheimer's diseaseRivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment.Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease.Safety and efficacy of rivastigmine in adolescents with Down syndrome: long-term follow-up.CHRNA7 polymorphisms and response to cholinesterase inhibitors in Alzheimer's diseaseAlzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection?Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story.Two cases of Alzheimer's disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil.A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.Pharmacological Treatment of Alzheimer's Disease: Is it Progressing Adequately?Pharmacogenomics in neurology: current state and future steps.Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation.Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors.Effect of apolipoprotein E and butyrylcholinesterase genotypes on cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's disease.Strategies for Continued Successful Treatment in Patients with Alzheimer’s Disease: An Overview of Switching Between Pharmacological Agents
P2860
Q24186551-68833511-01F7-4A54-916C-CBAAB82A088BQ24187067-5AB7FD57-0768-48E9-B961-BAE05161C1D1Q24241686-3191B50E-682C-4E8F-B1A7-80F96E167349Q33596451-25D45828-8DD8-4A0B-AD49-31CE9F1AA5F0Q33715239-2B8B9EE4-F96C-41B6-9D2C-96147E344327Q33968308-37DD4CF5-CBEE-4C4C-B46F-BE5D47C8A55EQ34327769-77A30BB5-BDFB-462F-AD11-D552F9CA93AFQ34511717-9328D8F4-01A5-4795-B3F7-712A8CBFC270Q35082774-A0122E45-C1BF-453B-9B7C-E44430DBDEA1Q35165703-992D3813-45E4-4317-B596-2FA655ACD5D7Q36475090-0FE9476B-B21A-4DE7-95C1-04BA9F5BF0E9Q36500123-24EA5F0C-BD7D-46A0-901F-7C7C92902806Q37070395-20AC3B83-806B-4EA6-8E39-6C434ED0BD33Q37198579-29282BAF-2B3E-4241-9E72-902243503347Q37967607-D23079AB-F618-4AF7-A191-A75F2E582CC5Q39136370-80E61DAE-2704-43CB-928E-88FE473D7F38Q39415447-1C7436EA-BE48-49D6-844D-2743BE5F1380Q47951730-3F465964-A8CA-498A-A18F-AD7F70C74070Q50800255-AD7818FE-0C72-44B2-AA49-8EE2CF4CF498Q51847733-0AC60D0D-A917-4299-850B-5D9DC1B325F7Q58794595-01252EAB-409E-4A2C-B89A-686EE8A11A1B
P2860
Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Effect of butyrylcholinesteras ...... ents with Alzheimer's disease.
@ast
Effect of butyrylcholinesteras ...... ents with Alzheimer's disease.
@en
Effect of butyrylcholinesteras ...... ents with Alzheimer's disease.
@nl
type
label
Effect of butyrylcholinesteras ...... ents with Alzheimer's disease.
@ast
Effect of butyrylcholinesteras ...... ents with Alzheimer's disease.
@en
Effect of butyrylcholinesteras ...... ents with Alzheimer's disease.
@nl
prefLabel
Effect of butyrylcholinesteras ...... ents with Alzheimer's disease.
@ast
Effect of butyrylcholinesteras ...... ents with Alzheimer's disease.
@en
Effect of butyrylcholinesteras ...... ents with Alzheimer's disease.
@nl
P2093
P1476
Effect of butyrylcholinesteras ...... ents with Alzheimer's disease.
@en
P2093
Giuseppe Gambina
Günter Rapatz
Howard Bergman
Jennifer Nagel
Joanne Meyer
Rafael Blesa
Roger Bullock
Roger Lane
Yunsheng He
P304
P356
10.1097/01.FPC.0000220573.05714.AC
P577
2006-11-01T00:00:00Z